Mycobacterium tuberculosis exploits the PPM1A signaling pathway to block host macrophage apoptosis

Area of Science:

• Immunology
• Microbiology
• Cell Biology

Background:

• Macrophage apoptosis suppression is crucial for Mycobacterium tuberculosis (Mtb) intracellular replication and antibiotic resistance.
• Mtb infection upregulates host phosphatase PPM1A, impairing macrophage antibacterial responses.

Purpose of the Study:

• To establish PPM1A as a target for Mtb to suppress macrophage apoptosis.
• To investigate therapeutic strategies for eliminating intracellular Mtb by inducing macrophage apoptosis.

Main Methods:

• Overexpression and targeted depletion (shRNA) of PPM1A in Mtb-infected macrophages.
• Inhibition of PPM1A activity using sanguinarine.
• Activation of c-Jun N-terminal kinase (JNK) using anisomycin and JNK inhibitors.
• Assessment of macrophage apoptosis and intracellular Mtb viability after treatment with rifampicin.

Main Results:

• PPM1A overexpression suppressed Mtb-induced macrophage apoptosis by inactivating JNK.
• PPM1A depletion or inhibition restored JNK activation and increased apoptosis in Mtb-infected macrophages.
• JNK activation selectively induced apoptosis in Mtb-infected human macrophages.
• A
• Conclusions: Drug-induced selective apoptosis of Mtb-infected macrophages is a viable strategy for enhancing antibiotic efficacy against intracellular Mtb.
• Meta_Description: 'Targeting PPM1A and JNK pathways to induce apoptosis in Mtb-infected macrophages offers a novel therapeutic strategy for tuberculosis treatment.'

Conclusions:

• Targeting PPM1A or activating JNK pathways can overcome Mtb's suppression of macrophage apoptosis.
• Selective induction of apoptosis in Mtb-infected macrophages enhances the efficacy of antibiotics like rifampicin.
• This research validates a
• Main_Results